1. Understanding PAD

2. Goals

3. Peripheral Arterial Disease

5. Outcomes in Patients With Symptomatic PAD

6. Risk Factors for PAD

7. Physical Findings in PAD

8. Noninvasive Physiologic Tests for PAD

10. PAD Risk-Reduction Therapies

12. Exercise in PAD

13. Pharmacotherapy for Claudication FDA-Approved Drugs

15. Indications for Revascularization

16. Latest Advances in Pharmacotherapy

17. Vorapaxar -- Efficacy at 3 Years MI or PAD (No Stroke/TIA)

20. Vorapaxar and Limb Vascular Efficacy

21. Adverse Limb Events Prevention

24. Ongoing Investigation of Antithrombotics in PAD

25. Underused Available Therapies

26. Summary

27. Abbreviations

28. Abbreviations (cont)